European Silent heart attack Market Trends, Growth, Analysis and Forecast - 2025

European silent heart attack market is estimated to grow modestly, at a CAGR of around 6.5%, during the forecast period. The huge demand for cardiology surgeries and devices and growing lifestyle-oriented diseases such as CVD, CHD, stroke, and other heart related diseases are offering growth to the market in the region. Europe has quality healthcare system; however, the surgeries and medical devices are costly. In Europe, in April 2019, Britain heart Foundation has launched a global competition namely “The Big Bit Challenge” with the prize amounting to $39 million to propose a transformational solution to any CVD disease. Europe has a huge economic burden of lifestyle-oriented diseases such as CVD, CHD, MI treatment, stroke, and other heart diseases.

Get Sample Copy of European Silent heart attack Market at: https://www.omrglobal.com/request-sample/european-silent-heart-attack-market

The companies which are contributing to the growth of the European silent heart attack market include AstraZeneca PLC, Bayer AG, Siemens AG, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim GmbH, and GlaxoSmithKline Plc.

Moreover, Europe region which includes UK, Spain, European, France, Italy, Sweden, and other EU countries have significant number of CVD patients with heart diseases which is giving rise to the adoption of robotic surgeries and hybrid operating rooms. European silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery.

For More Information, get A full report of European Silent heart attack Market is available at: https://www.omrglobal.com/industry-reports/european-silent-heart-attack-market

Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centres (ASCs). ECG is the most used technology to diagnose silent heart attack. ECG provides insights about heart rate, indicates, if there is enlargement of the heart due to high blood pressure (hypertension) or evidence of a previous heart attack. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.

Market Segmentation

European Silent Heart Attack Market by Diagnosis

• Electrocardiography (ECG)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)

European Silent Heart Attack Market by Treatment

• Medication
• Surgery
• Angioplasty
• Bypass Surgery
• Heart Transplant

European Silent Heart Attack Market by End-Users

• Hospital & Clinics
• Ambulatory Surgical Centers

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-silent-heart-attack-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.